Acute pain · Non-opioid options · Journavx (suzetrigine)

Online acute pain evaluation — non-opioid options including Journavx

For a recent injury, strain, dental or post-procedure pain, a licensed clinician reviews what happened and what you've tried. If it fits, non-opioid treatment such as an anti-inflammatory or Journavx (suzetrigine) can be prescribed and sent to your pharmacy. Ondoc does not prescribe opioids.

Board-certified clinicians · No membership required · Medicare, commercial insurance or $50 self-pay for the Ondoc visit

Choose a time or continue without one

Tell us what you need.

Acute pain evaluation
Insurance or self-pay?

Non-opioid only

Options include anti-inflammatories, muscle relaxants, and Journavx (suzetrigine), the first non-opioid pain medicine of its kind, which is not a controlled substance.

Short-term pain

Journavx is approved for moderate-to-severe acute pain in adults. Use for acute pain has not been studied beyond 14 days; this is not an established chronic-pain treatment.

Insurance or self-pay

Use your insurance, or pay the standard self-pay visit fee. Journavx is a brand medicine; your plan and pharmacy decide what it costs.

Your pharmacy

If you are prescribed a medicine, it is sent to the pharmacy you choose.

What you get

  • Video visit with a licensed clinician
  • Review of the injury or cause, your medicines and health history
  • Non-opioid treatment plan, including Journavx
  • Clear signs that mean you need in-person or emergency care

Recent pain needs a cause, not just a stronger pill

A strain, dental problem or post-procedure pain can have different treatment needs. An online clinician can discuss what happened, assess whether a non-opioid medicine fits and identify when an examination is needed. Journavx is one possible option for adult acute pain, not a guaranteed prescription or a replacement for treating the injury or dental cause.

Tooth swelling or a suspected dental infection needs dental assessment: when antibiotics help a tooth infection. Persistent back pain has its own evaluation: low-back pain.

Reference: FDA Journavx prescribing information.

FAQs

What is Journavx?

Journavx (suzetrigine) is an FDA-approved non-opioid pill for moderate-to-severe acute pain in adults. It blocks the NaV1.8 pain signal in nerves outside the brain, is not addictive in the way opioids are, and is not a controlled substance.

Can I just order Journavx?

No. A clinician evaluates your pain first. Journavx is not right for everyone: it interacts with some common medicines, isn't recommended with certain liver problems, and can make hormonal birth control less effective.

Is Journavx an opioid, and can it treat chronic pain?

Suzetrigine targets the NaV1.8 channel involved in pain signals outside the brain and is not an opioid or controlled substance. Its FDA indication is moderate-to-severe acute pain in adults, not chronic pain. Safety and effectiveness for acute use beyond 14 days have not been studied; persistent pain requires reassessment rather than an automatic refill.

What should I discuss before taking Journavx?

Tell the clinician how the pain started and about all medicines and supplements, liver conditions and pregnancy or breastfeeding. Some CYP3A medicines interact with suzetrigine, grapefruit should be avoided, and additional contraceptive precautions may be needed. The clinician and pharmacist determine the appropriate medication instructions. A prescription does not replace examination, imaging or dental care when the cause needs those.

Does Ondoc prescribe opioids?

Ondoc's acute-pain service uses non-opioid options and does not offer an opioid pain program.

When should I go in person instead?

Go to urgent care or the emergency room for a possible broken bone, a deep wound, a head injury, chest pain, severe belly pain, or pain with fever, weakness or numbness.

Can I use insurance?

Yes. Choose your insurance when you start. If you'd rather not use insurance, you can pay the standard self-pay visit fee.

Medically reviewed by Dr. Ikechukwu Ogbu, MD